New psoriasis treatment aims to match proven drug
Disease control
Ongoing
This study is testing if a new drug called CMAB015 works as well as an already-approved drug, secukinumab, for treating moderate to severe plaque psoriasis. About 336 adults will receive injections of one of the two drugs for a year to see which is better at clearing skin and is …
Phase: PHASE3 • Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC